Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Pembrolizumab in Children, Adolescents, and Young Adults with High-Risk Classic Hodgkin Lymphoma (cHL) with Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study

Blood (2024) 144 (Supplement 1): 3055.

https://doi.org/10.1182/blood-2024-199675

Published: 2024

Journal Articles

Circulating Cell-Free DNA in Classical Hodgkin Lymphoma in Children, Adolescents and Young Adults. Results from the Holy Study, a French Ancillary Study of Euronet PHL-C2 Protocol

Blood (2024) 144 (Supplement 1): 1592.

https://doi.org/10.1182/blood-2024-194387

Published: 2024

Journal Articles

R-CVP in Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children

Thi An VU, Laura Olivier, Mathieu Simonin, Sabah Boudjemaa, Bénédicte Jonca, Charlotte Rigaud, Nathalie Garnier, Ludovic Mansuy, Catherine Curtillet, Pauline Treguier, Florent Neumann, Sebastien Heritier, Marie-Emilie Dourthe, Judith Landman-Parker

Blood (2024) 144 (Supplement 1): 6349.

https://doi.org/10.1182/blood-2024-209703

Published: 2024

Journal Articles

Pembrolizumab (pembro) in Children and Young Adults with High-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Updated Results from the Phase 2 Keynote-667 Study

Christine Mauz-Koerholz, Auke Beishuizen, Luciana Vinti, Antony Ceraulo, Gerard Michel, Michaela Cepelova, Franca Fagioli, Constantino Sabado Alvarez, Stephane Ducassou, Salvatore Buffardi, Maitane Andión Catalan, Brad Hoppe, Frank Keller, Kara M. Kelly, Lisa Giulino Roth, Judith Landman-Parker, Juan Shen, Pallavi Pillai, Stephen Daw

Blood (2023) 142 (Supplement 1): 3063.

https://doi.org/10.1182/blood-2023-187028

Published: 2023

Journal Articles

DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity

Charlotte Boussard, Laure Delage, Tania Gajardo, Alexandre Kauskot, Maxime Batignes, Nicolas Goudin, Marie-Claude Stolzenberg, Camille Brunaud, Patricia Panikulam, Quentin Riller, Maryse Moya-Nilges, Jean Solarz, Christelle Repérant, Béatrice Durel, Jean-Claude Bordet, Olivier Pellé, Corinne Lebreton, Aude Magérus, Vithura Pirabakaran, Pablo Vargas, Sébastien Dupichaud, Marie Jeanpierre, Angélique Vinit, Mohammed Zarhrate, Cécile Masson, Nathalie Aladjidi, Peter D. Arkwright, Brigitte Bader-Meunier, Sandrine Baron Joly, Joy Benadiba, Elise Bernard, Dominique Berrebi, Christine Bodemer, Martin Castelle, Fabienne Charbit-Henrion, Marwa Chbihi, Agathe Debray, Philippe Drabent, Sylvie Fraitag, Miguel Hié, Judith Landman-Parker, Ludovic Lhermitte, Despina Moshous, Pierre Rohrlich, Frank Ruemmele, Anne Welfringer-Morin, Maud Tusseau, Alexandre Belot, Nadine Cerf-Bensussan, Marie Roelens, Capucine Picard, Bénédicte Neven, Alain Fischer, Isabelle Callebaut, Mickaël Ménager, Fernando E. Sepulveda, Frédéric Adam, Frédéric Rieux-Laucat

Blood (2023) 141 (22): 2713–2726.

https://doi.org/10.1182/blood.2022018486

Published: 2023

Includes: Supplemental data

Journal Articles

Should Adolescents and Young Adults with Hodgkin Lymphoma be Treated As Children or Adults?

Lucille Lew-Derivry, Pauline Brice, Camille Bigenwald, Judith Landman-Parker, Thierry Leblanc, Florian Chevillon, Nicolas Boissel, Aurélie Cabannes-Hamy

Blood (2022) 140 (Supplement 1): 1749–1750.

https://doi.org/10.1182/blood-2022-157046

Published: 2022

Journal Articles

Pediatric-Onset Evans Syndrome Is Associated with Broad Immunopathological Manifestations, High Treatment Burden and Mortality in Long-Term Follow-up

Blood (2020) 136 (Supplement 1): 20–22.

https://doi.org/10.1182/blood-2020-133778

Published: 2020

Journal Articles

IL10RA modulates crizotinib sensitivity in NPM1-ALK + anaplastic large cell lymphoma

Blood (2020) 136 (14): 1657–1669.

https://doi.org/10.1182/blood.2019003793

Published: 2020

Includes: Supplemental data

Journal Articles

Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements

Blood (2019) 134 (16): 1351–1355.

https://doi.org/10.1182/blood.2019001244

Published: 2019

Includes: Supplemental data

Journal Articles

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia

Arnaud Petit, Amélie Trinquand, Sylvie Chevret, Paola Ballerini, Jean-Michel Cayuela, Nathalie Grardel, Aurore Touzart, Benoit Brethon, Hélène Lapillonne, Claudine Schmitt, Sandrine Thouvenin, Gerard Michel, Claude Preudhomme, Jean Soulier, Judith Landman-Parker, Guy Leverger, Elizabeth Macintyre, André Baruchel, Vahid Asnafi

Blood (2018) 131 (3): 289–300.

https://doi.org/10.1182/blood-2017-04-778829

Published: 2018

Includes: Supplemental data

Journal Articles

Oncogenetic Risk Classification Based on NOTCH1/FBXW7/RAS/PTEN Mutation Profiles Improves Outcome Prediction in Pediatric T-Cell Acute Lymphoblastic Leukemia, Treated According the Fralle 2000 T Guidelines

Arnaud Petit, MD PhD, Amélie Trinquand, MD, Sylvie Chevret, MD PhD, Paola Fabiola Ballerini, MD PhD, Jean-Michel Cayuela, MD, Nathalie Grardel, MD, Aurore Touzart, MD, Benoit Brethon, MD, Hélène Lapillonne, MD PhD, Pascal Chastagner, MD, Claire Berger, MD, Gerard Michel, MD, Claude Preudhomme, MD PhD, Jean Soulier, MD PhD, Judith Landman-Parker, MD, Guy Leverger, MD, Elizabeth Macintyre, MD PhD, Andre Baruchel, MD PhD, Vahid Asnafi, MD PhD

Blood (2016) 128 (22): 1083.

https://doi.org/10.1182/blood.V128.22.1083.1083

Published: 2016

Journal Articles

Advanced Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) in Children and Adolescents : Retrospective Study from Sfce and Ukccssg

Roques Gaelle, physician fellow, Ananth Shankar, MD, Thierry Leblanc, MD, Claudine Schmitt, MD, Janis Hayward, MD, Helene Pacquement, Anne Lambilliotte, Nathalie Aladjidi, MD, Stephanie gorde-Grosjean, Hewitt Martin, MD, Stephanie Haouy, Samuel Abbou, Dominique Plantaz, MD PhD, Genevieve Plat, Georgina Hall, BSc, PhD MBBS, FRCP, FRCPath, Judith Landman-Parker, Pr

Blood (2014) 124 (21): 4413.

https://doi.org/10.1182/blood.V124.21.4413.4413

Published: 2014

Journal Articles

Modeling Growth Of Pediatric T-ALL In Vivo and In Vitro : Clinical Meaning and Activation Of The NFkB Pathway

Sandrine Poglio, PhD, Xavier Cahu, MD, Benjamin Uzan, PhD, Hélène Lapillonne, MD, Thierry Leblanc, MD, André Baruchel, MD, Judith Landman-Parker, MD, PhD, Arnaud Petit, MD, Frederic Baleydier, MD, PhD, Sophie Amsellem, PhD, Paola Ballerini, MD, PhD, Françoise Pflumio, PhD

Blood (2013) 122 (21): 2571.

https://doi.org/10.1182/blood.V122.21.2571.2571

Published: 2013

Journal Articles

New Design Of Human T-ALL Transplantation In NSG Mice Uncovers The Major Role Of CD31/PECAM1 In The Central Nervous System Infiltration

Sandrine Poglio, PhD, Anne-Laure Bauchet, José Ramon Pineda, PhD, Caroline Deswarte, Thierry Leblanc, MD, André Baruchel, MD, Paola Ballerini, MD, PhD, Judith Landman-Parker, MD, PhD, Iannis Aifantis, PhD, François Boussin, PhD, Françoise Pflumio, PhD

Blood (2013) 122 (21): 1436.

https://doi.org/10.1182/blood.V122.21.1436.1436

Published: 2013

Journal Articles

Phase 1/2 Study Of Brentuximab Vedotin In Pediatric Patients With Relapsed Or Refractory (R/R) Hodgkin Lymphoma (HL) Or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 Data For Brentuximab Vedotin 1.8 Mg/Kg In The HL Study Arm

Franco Locatelli, MD, Kathleen A Neville, MD, MS, Angelo Rosolen, MD, Judith Landman-Parker, MD, Nathalie Aladjidi, MD, Auke Beishuizen, MD, Stephen Daw, BSc Hons, MBChB, MRCP, Lia Gore, MD, Anna R.K. Franklin, MD, Adedigbo Fasanmade, PhD, Jingyuan Wang, PhD, Jessica Sachs, MD, Christine Mauz-Koerholz, MD

Blood (2013) 122 (21): 4378.

https://doi.org/10.1182/blood.V122.21.4378.4378

Published: 2013

Journal Articles

A Study of Immune Deficiency as Risk Factor of Hodgkin's Lymphoma in Children.

Leila Hamdi, Rita Creidy, Jr., Patricia Rince, Karim Abbed, Jacqueline Clavel, Martine Raphael, Sr., Judith Landman-Parker, Caroline Besson, MD

Blood (2009) 114 (22): 1559.

https://doi.org/10.1182/blood.V114.22.1559.1559

Published: 2009

Journal Articles

SPRED1 disorder and predisposition to leukemia in children

Eric Pasmant, Paola Ballerini, Helene Lapillonne, Christine Perot, Dominique Vidaud, Guy Leverger, Judith Landman-Parker

Blood (2009) 114 (5): 1131.

https://doi.org/10.1182/blood-2009-04-218503

Published: 2009

Journal Articles

NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity

Florence Armstrong, Philippe Brunet de la Grange, Bastien Gerby, Marie-Christine Rouyez, Julien Calvo, Michaéla Fontenay, Nicolas Boissel, Hervé Dombret, André Baruchel, Judith Landman-Parker, Paul-Henri Roméo, Paola Ballerini, Françoise Pflumio

Blood (2009) 113 (8): 1730–1740.

https://doi.org/10.1182/blood-2008-02-138172

Published: 2009

Includes: Supplemental data

Journal Articles

High-Dose Methotrexate Seems to Benefit Only to Standard-Risk BCP-ALL Patients with Good Early Response to Chemotherapy: Final Analysis of the FRALLE93B Study

Blood (2008) 112 (11): 10.

https://doi.org/10.1182/blood.V112.11.10.10

Published: 2008

Journal Articles

Prognostic Significance of SALL4 Expression Levels in Paediatric Acute Myeloid Leukaemia (AML).

Paola Ballerini, Pierre-Yves Boelle, Caroline Deswarte, Anne Auvrignon, Gabrielle Couchy, Judith Landman- Parker, Alain Robert, Brigitte Nelken, Mircea Adam, Helene Lapillonne, Eric Delabesse, PhD, Christine Perot, Jean Luc Lai, Nicole Dastugue, Claude Preudhomme, Jessica Zucman-Rossi, Guy Leverger

Blood (2008) 112 (11): 2243.

https://doi.org/10.1182/blood.V112.11.2243.2243

Published: 2008

NARROW

Pembrolizumab in Children, Adolescents, and Young Adults with High-Risk Classic Hodgkin Lymphoma (cHL) with Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study

Circulating Cell-Free DNA in Classical Hodgkin Lymphoma in Children, Adolescents and Young Adults. Results from the Holy Study, a French Ancillary Study of Euronet PHL-C2 Protocol

R-CVP in Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children

Pembrolizumab (pembro) in Children and Young Adults with High-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Updated Results from the Phase 2 Keynote-667 Study

DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity

Should Adolescents and Young Adults with Hodgkin Lymphoma be Treated As Children or Adults?

Pediatric-Onset Evans Syndrome Is Associated with Broad Immunopathological Manifestations, High Treatment Burden and Mortality in Long-Term Follow-up

IL10RA modulates crizotinib sensitivity in NPM1-ALK + anaplastic large cell lymphoma

Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia

Oncogenetic Risk Classification Based on NOTCH1/FBXW7/RAS/PTEN Mutation Profiles Improves Outcome Prediction in Pediatric T-Cell Acute Lymphoblastic Leukemia, Treated According the Fralle 2000 T Guidelines

Advanced Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) in Children and Adolescents : Retrospective Study from Sfce and Ukccssg

Modeling Growth Of Pediatric T-ALL In Vivo and In Vitro : Clinical Meaning and Activation Of The NFkB Pathway

New Design Of Human T-ALL Transplantation In NSG Mice Uncovers The Major Role Of CD31/PECAM1 In The Central Nervous System Infiltration

Phase 1/2 Study Of Brentuximab Vedotin In Pediatric Patients With Relapsed Or Refractory (R/R) Hodgkin Lymphoma (HL) Or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 Data For Brentuximab Vedotin 1.8 Mg/Kg In The HL Study Arm

A Study of Immune Deficiency as Risk Factor of Hodgkin's Lymphoma in Children.

SPRED1 disorder and predisposition to leukemia in children

NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity

High-Dose Methotrexate Seems to Benefit Only to Standard-Risk BCP-ALL Patients with Good Early Response to Chemotherapy: Final Analysis of the FRALLE93B Study

Prognostic Significance of SALL4 Expression Levels in Paediatric Acute Myeloid Leukaemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only